Oleuropein modulates glioblastoma miRNA pattern different from <i>Olea europaea</i> leaf extract.

Tezcan G., Aksoy S., Tunca B., Bekar A., Mutlu M., Cecener G., ...More

Human & experimental toxicology, vol.38, no.9, pp.1102-1110, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 9
  • Publication Date: 2019
  • Doi Number: 10.1177/0960327119855123
  • Journal Name: Human & experimental toxicology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1102-1110
  • Keywords: Glioblastoma multiforme, temozolomide, Olea europaea, oleuropein, ADJUVANT TEMOZOLOMIDE, OVARIAN-CANCER, EXPRESSION, STAT3, OLIVE, CELLS, LET-7, MGMT, IDENTIFICATION, ANGIOGENESIS
  • Bursa Uludag University Affiliated: Yes


Glioblastoma (GBM) is the most prevalent and deadliest subtype of glioma. Despite current innovations in existing therapeutic modalities, GBM remains incurable, and alternative therapies are required. Previously, we demonstrated that Olea europaea leaf extract (OLE) kills GBM cells by modulating miR-181b, miR-137, miR-153 and Let-7d expression. However, although oleuropein (OL) is the main compound in OLE, its role in the antitumour effect of OLE remains unknown. This study determined the effect of OL on GBM cell line T98G and compared the results with our previous findings regarding the effect of OLE on the same cell line. The antiproliferative activity of OL and its effect on temozolomide (TMZ) response were tested inT98G cells using WST-1 assay. OL inhibition was evaluated using one-way analysis of variance with Tukey's post hoc test. The effect of OL on miR-181b, miR-137, miR-153 and Let-7d expression was assessed using quantitative reverse transcription polymerase chain reaction. Fold differences in expression between untreated, OL or OL + TMZ-treated samples were calculated using 2(-Delta Ct) method. Significance was evaluated using an independent sample t-test. Treatment with 277.5 and 555 mu M OL resulted in 39.51% and 75.40% reductions in T98G cells within 24 h. Coadministration of 325 mu M TMZ and 277.5 or 555 mu M, OL caused 2.08- and 2.83-fold increases, respectively, in the therapeutic effect of TMZ. OL + TMZ significantly increased microRNA expression, particularly Let-7d, than OLE. In conclusion, OL has an antitumour effect on GBM cells mainly via regulation of Let-7d expression. The present results also indicate other minor compounds in OLE play important anticancer roles.